BridgeMD
New treatment option for Fibrin Blood Clot
Official title Ovarian Hyperstimulation and Fibrin Clot Properties.
ClinicalTrials.gov ID: NCT04166825
What this study is testing
- What it's testing
- The impact evaluation of ovarian hyperstimulation on coagulation and fibrinolysis in infertile women. Comparative analysis between different ovarian stimulation protocols on thrombin formation and efficiency of fibrinolysis in women diagnosed with infertility.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only
You may be able to join if
- infertility defined based on the WHO 2010 criteria
You likely can't join if
- ovarian involvement
- oral contraceptives use within previous 3 months
- dienogest therapy within 3 months until ART
- thrombotic events in the medical history
- severe hypertension
- diabetes mellitus
See the full eligibility criteria
- infertility defined based on the WHO 2010 criteria
- ovarian involvement
- oral contraceptives use within previous 3 months
- dienogest therapy within 3 months until ART
- thrombotic events in the medical history
- severe hypertension
- diabetes mellitus
- the presence of known VTE risk factors, including obesity, recent major surgery with prolonged immobilization or trauma,
- deficiency of antithrombin, protein C or protein S,
- antiphospholipid syndrome,
- known malignancy,
- any chronic inflammatory diseases (e.g. rheumatoid arthritis)
- advanced chronic renal disease (estimated glomerular filtration rate [eGFR] \<30 ml/min),
- international normalized ratio (INR) more than 1.2 at the day of blood draw
- pregnancy.
The study team makes the final eligibility decision.
Where it's taking place
- Krakow, Małopolska, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Krakow, Małopolska, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.